Back to School: How biopharma can reboot drug development. Access exclusive analysis here

deCode pondering IPO

deCode Genetics (Reykjavik, Iceland) apparently is exploring the idea of selling

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE